Casi Pharmaceuticals Inc (CASIF)

CUSIP: G1933S101 | Healthcare · Biotechnology | Micro Cap | 51 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13D/AWei-Wu HE, Ph.D. with Emerging Technology Partners, LLC, ETP Global III Fund L.P., ETP Global Fund L.P., +3 more	23,985,535	58.8%	+5,000,000	May 18, 2026	No 13F filer matched
13D/AETP Global Fund III L.P.

Institutional Holders — Q3 2026

Sort by

West Paces Advisors Inc.100

0.0% of portfolio$11

				Style	Turnover	Location	Filed
West Paces Advisors Inc.	100	$11	0.0%	ETF	Low	Atlanta, GA	2026-10-13

13D/AWei-Wu HE, Ph.D.23,985,535

58.8% of class · May 18, 2026+5,000,000

with Emerging Technology Partners, LLC, ETP Global III Fund L.P., ETP Global Fund L.P., +3 more

No 13F filer matched

13D/AETP Global Fund III L.P.10,000,000

32.7% of class · Feb 9, 2026+5,000,000

No 13F filer matched

13D/AJames Huang4,651,527

22.5% of class · Dec 16, 2025+989,956

with Panacea Venture Healthcare Fund II, L.P., Panacea Venture Healthcare Fund II GP Company, Ltd., Panacea Innovation Limited

No 13F filer matched

13D/ASparkle Byte LTD1,019,852

5.0% of class · Sep 30, 2025New 5%+ stake

with Xizang Hexie Enterprise Management Co., Ltd.

No 13F filer matched

13D/AZhou Quan992,638

4.8% of class · Sep 30, 2025Newly reported

with Idg-Accel China Growth Fund III Associates L.P., Idg-Accel China Growth Fund III L.P., Idg-Accel China Growth Fund GP III Associates Ltd., +2 more

No 13F filer matched